MIBio 2026
Donate Join us

MIBio 2026

Date

14 October 2026

Subject areas

Industry , Chemical Biology and Medicinal , Biological

Location

Cambridge, UK

MIBio 2026 Main Image

We are delighted to announce the 14th MIBio conference, which will take place at the Howard Theatre, Downing College, Cambridge, on 14 October 2026.

MIBio 2026 will bring together leading experts from both industry and academia to explore how the latest discoveries in molecular interactions can be leveraged to develop better therapeutic products that are more effective, patient-friendly, and safe.

Increasing complexity of new therapeutics and growing demands for patient compliance create a strong need for advanced drug delivery technologies and streamlined development processes.  Characterization techniques and regulatory processes must respond to a range of novel therapeutic modalities under development. Prefilled devices have become the norm, which fuels innovation in safe and convenient delivery of larger volumes or more concentrated dosage forms. Peptide therapeutics are back in the spotlight for treatment of chronic conditions, which drives innovation in their more efficient delivery via the oral route. MIBio 2026 will delve into the current state-of-the-art and potential future developments in these pivotal areas.

We anticipate welcoming approximately 100 delegates from the biopharma industry, academia, and technology suppliers, creating a stimulating environment for new collaborations and breakthroughs in drug product development.

We invite abstract submissions for poster presentations and welcome applications for sponsorship and exhibitor opportunities. Join us at MIBio 2026 to engage in inspiring discussions and shape the future of biopharmaceutical innovation.

We look forward to seeing you there!

Deadlines

Speakers

Default Person Image

Paul Varley

Alchemab Therapeutics

UK

Default Person Image

Miranda Newbery

Med HF

UK

Default Person Image

Ryte Poskute

AstraZeneca

UK

Default Person Image

David Brayden

University College Dublin

UK

Default Person Image

Joel Gresham

Crux Product Design

UK

Default Person Image

Carine Huon

Sanofi

France

Committees

Default Person Image

Jan Jezek

Arecor

UK

Default Person Image

Bin Yang

AstraZeneca

UK

Default Person Image

Nicholas J Darton

AstraZeneca

UK

Default Person Image

Tejash Shah

GSK

UK

Default Person Image

Stephen Harding

University of Nottingham

UK

Default Person Image

Bernardo Parez-Ramirez

Danofi

United States

Event details

Programme subject to change

08:00 Registration opens

09:00 Opening remarks

09:15 What Have Monoclonal Antibodies Ever Done For Us Paul Varley | Chief Development Officer, Alchemab Therapeutics

09:45 Human Factors in Platform Device Development Miranda Newbery | Med HF

10:15 Speed Networking

11:15 Analytical Challenges and Strategies for Mispaired Species Detection and Quantitation in Duet mAb Molecules Ryte Poskute | Senior Scientist, AstraZeneca

11:45 Exhibitors highlights

12:30 Lunch Break, Exhibition and Posters

13:30 Introduction to the afternoon session

13:45 Challenges in non-injected administration of peptides: proof-of principle for oromucosal administration of peptides in large animals David Brayden | Professor of Advanced Drug Delivery, University College Dublin

14:15 Discussion panel

15:15 Coffee break, Exhibition & Posters

16:00 A decade of drug delivery: how to advance the frontiers of injectable technologies Joel Gresham | Chief Scientist, Crux Product Design

16:30 Holistic Container Closure Integrity Testing for Vials: Technical Challenges and Solutions Carine Huon | Senior Container Closure Integrity Scientist, Sanofi

17:00 Concluding remarks

17:10 Conference ends

CALL FOR POSTERS

Abstracts for poster presentations at MIBio 2026 are now being invited.

Please submit a 200 – 250 words abstract as a Word document to: [email protected]

Please note that you will need to register to be able to present your poster at MIBio 2026.

DEADLINE - Monday 05 October 2026

POSTER AWARD - We are delighted to announce that a Poster Award will be presented at this year's conference. Please note that registration is required to participate.

POSTER SIZE - If your abstract has been accepted - the poster boards at 2m high x 1m wide so suitable for A0. We have to use Velcro (which will be provided) so not suitable for cloth posters.

Deadlines

RSC Joint Colloid Group

Royal Society of Chemistry (RSC)

The Howard Theatre, Downing College, Cambridge

The Howard Theatre, Downing College, Cambridge, Cambridge, UK

Allow cookies to view content.

Venue details URL